Fitlife Brands, Inc.
FTLFNasdaqCIK 1374328HealthcareFiscal year ends Dec 31
Reports and events: 246 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0916:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-029979 |
| 2026-08-1308:30 ET | 8-K | 2.02 Results of operations; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-027493 |
| 2026-08-1307:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027478 |
| 2026-06-2612:15 ET | DEF 14A | Proxy statementPeriod 2026-08-11 | 0001437749-26-021797 |
| 2026-05-2216:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-26-018249 |
| 2026-05-1414:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-016983 |
| 2026-05-1407:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016875 |
| 2026-04-2117:00 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001437749-26-012937 |
| 2026-04-0716:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-011607 |
| 2026-04-0108:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-010811 |
| 2026-03-3116:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010680 |
| 2025-12-1008:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-037314 |
| 2025-11-1307:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-034610 |
| 2025-11-1307:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034607 |
| 2025-10-2007:30 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001437749-25-031312 |
| 2025-08-1916:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-027367 |
| 2025-08-1407:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-026674 |
| 2025-08-1407:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026661 |
| 2025-08-1316:49 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-026555 |
| 2025-08-1107:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-025813 |
| 2025-08-0507:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-024707 |
| 2025-06-2417:00 ET | DEF 14A | Proxy statementPeriod 2025-08-12 | 0001437749-25-021173 |
| 2025-05-1508:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-016991 |
| 2025-05-1507:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-016990 |
| 2025-04-2918:43 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001437749-25-013385 |
| 2025-04-2808:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013231 |
| 2025-04-2207:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-012595 |
| 2025-03-2714:38 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-009584 |
| 2025-03-2707:38 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-009469 |
| 2025-03-1308:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-007389 |
| 2025-02-0517:11 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-002916 |
| 2024-12-1608:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-037519 |
| 2024-11-1808:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-035540 |
| 2024-11-1407:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-035028 |
| 2024-11-1407:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-035027 |
| 2024-08-1416:18 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-026822 |
| 2024-08-1407:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-026562 |
| 2024-07-0508:00 ET | DEF 14A | Proxy statementPeriod 2024-08-13 | 0001437749-24-022224 |
| 2024-07-0507:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-022223 |
| 2024-05-1407:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-016353 |
| 2024-05-1407:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-016354 |
| 2024-05-0807:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-015202 |
| 2024-04-2211:48 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001437749-24-012657 |
| 2024-03-2917:17 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-010119 |
| 2024-03-2916:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-010094 |
| 2024-03-1512:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-008039 |
| 2023-11-1408:34 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-031771 |
| 2023-11-1307:31 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-031385 |
| 2023-10-1307:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-028182 |
| 2023-09-2717:17 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-026948 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.